Carbetapentane and chlorpheniramine and Ocrelizumab Intravenous
Determining the interaction of Carbetapentane and chlorpheniramine and Ocrelizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbetapentane / chlorpheniramine
Brand name: C-Tanna 12, Tannic-12 S, Tussizone-12 RF, Tannate 12 S, Trionate, Tussi-12, Tussi-12S, Tustan 12S
Synonyms: n.a.
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbetapentane and chlorpheniramine-Ocrevus
- Carbetapentane and chlorpheniramine-Octagam
- Carbetapentane and chlorpheniramine-Octagam Gammagard S/D
- Carbetapentane and chlorpheniramine-Octocaine
- Carbetapentane and chlorpheniramine-Octocaine 100
- Carbetapentane and chlorpheniramine-OctreoScan
- Ocrelizumab Intravenous-Carbetapentane and guaifenesin
- Ocrelizumab Intravenous-Carbetapentane and pseudoephedrine
- Ocrelizumab Intravenous-Carbidopa
- Ocrelizumab Intravenous-Carbidopa and levodopa
- Ocrelizumab Intravenous-Carbidopa and levodopa enteral
- Ocrelizumab Intravenous-Carbidopa and Levodopa Enteral Suspension